201 related articles for article (PubMed ID: 6968847)
1. Inhibition of B-lymphocyte clonal proliferation by spleen cells from plasmacytoma-bearing mice.
Hamburger AW
J Natl Cancer Inst; 1980 Dec; 65(6):1337-43. PubMed ID: 6968847
[TBL] [Abstract][Full Text] [Related]
2. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.
Fenton MR; Havas HF
J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide-induced appearance of immunopotentiating T-cells in the spleens of mice bearing a large MOPC-315 tumor.
Ye QW; Mokyr MB
Cancer Res; 1984 Sep; 44(9):3873-9. PubMed ID: 6611201
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the humoral immune response by plasmacytomas: mediation by adherent mononuclear cells.
Kolb JP; Arrian S; Zolla-Pazner S
J Immunol; 1977 Feb; 118(2):702-9. PubMed ID: 138708
[TBL] [Abstract][Full Text] [Related]
5. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
Mokyr MB; Ye QW
Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
[TBL] [Abstract][Full Text] [Related]
6. Regulation of myeloma growth in vitro by idiotype-specific T lymphocytes.
Flood PM; Philipps C; Taupier MA; Schreiber H
J Immunol; 1980 Jan; 124(1):424-30. PubMed ID: 6965296
[TBL] [Abstract][Full Text] [Related]
7. Immunocompetence status as related to growth progression of mouse MOPC-315 plasmacytoma.
Rashid G; Ophir R; Pecht M; Ben-Efraim S
In Vivo; 1989; 3(4):279-84. PubMed ID: 2535271
[TBL] [Abstract][Full Text] [Related]
8. Matching of chemotherapy to mouse strain and lymphoid tumor type to prevent tumor-induced suppression of specific T- and B-cell functions.
Faanes RB; Merluzzi VJ; Williams N; Tarnowski GS; Ralph P
Cancer Res; 1979 Nov; 39(11):4564-74. PubMed ID: 315269
[TBL] [Abstract][Full Text] [Related]
9. Control of B cell proliferation: arrest of B cells in late G1 underlies immunosuppression induced by plasma cell tumors.
Berman JE; Zolla-Pazner S
J Immunol; 1987 May; 138(9):2805-12. PubMed ID: 3494771
[TBL] [Abstract][Full Text] [Related]
10. Myeloma-induced immunosuppression: a multistep mechanism.
Katzmann JA
J Immunol; 1978 Oct; 121(4):1405-9. PubMed ID: 701801
[TBL] [Abstract][Full Text] [Related]
11. The role of T, B and adherent cells in the in vitro immune response of TEPC-183-bearing mice.
Patel M; Havas HF
Immunology; 1982 May; 46(1):97-105. PubMed ID: 6978846
[TBL] [Abstract][Full Text] [Related]
12. The nature of the cells generating B-lymphocyte colonies in vitro.
Metcalf D; Wilson JW; Shortman K; Miller JF; Stocker J
J Cell Physiol; 1976 May; 88(1):107-16. PubMed ID: 1083394
[TBL] [Abstract][Full Text] [Related]
13. [Neoplastic-lymphocytic hybrid cell lines].
Izdebska-Szymona K
Postepy Hig Med Dosw; 1979; 33(5):465-77. PubMed ID: 398040
[No Abstract] [Full Text] [Related]
14. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
Majlessi L; Bordenave G
Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
[TBL] [Abstract][Full Text] [Related]
15. B lymphocyte lineage cells in newborn and very young NZB mice: evidence for regulatory disorders affecting B cell formation.
Jyonouchi H; Kincade PW; Good RA; Gershwin ME
J Immunol; 1983 Nov; 131(5):2219-25. PubMed ID: 6605377
[TBL] [Abstract][Full Text] [Related]
16. Changes in B lineage cell population in liver and spleen of normal neonatal mice.
Jyonouchi H; Kincade PW
J Immunol; 1983 Apr; 130(4):1616-21. PubMed ID: 6601130
[TBL] [Abstract][Full Text] [Related]
17. Development of a bioassay for human myeloma colony-forming cells.
Hamburger AW; Salmon SE
Prog Clin Biol Res; 1980; 48():23-41. PubMed ID: 7208518
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression in BALB/c mice bearing the plasmacytoma TEPC-183: massive increase in red pulp macrophages induced by the tumour.
Joshua DE; Humphrey JH; Grennan D; Brown G
Immunology; 1980 Jun; 40(2):223-8. PubMed ID: 7409859
[TBL] [Abstract][Full Text] [Related]
19. Effect of splenectomy on the immune response of BALB/c mice bearing an immunoglobulin M plasmacytoma (TEPC-183).
Havas HF; Berney S; Goodis A; Schiffman G
Cancer Res; 1979 Sep; 39(9):3783-7. PubMed ID: 476702
[TBL] [Abstract][Full Text] [Related]
20. Cellular changes and antitumor responses in the plasmacytoma-bearing mouse following cyclophosphamide treatment.
Shanahan TC; Ceglowski WS; Havas HF
Cancer Res; 1985 Dec; 45(12 Pt 1):6463-70. PubMed ID: 2866030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
